Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.

Journal: Cancer Cell

Published: 2019-05-09

DOI: 10.1016/j.ccell.2019.04.007

Affiliations: 23

Authors: 35

Go to article
Institutions FC
State Key Laboratory of Oncology in South China, SYSU, China 0.14
The People's Liberation Army No. 302 Hospital (PLA No. 302 Hospital), China 0.11
RIKEN Laboratory for Cancer Genomics, Japan 0.09
Biomedical Pioneering Innovation Center (BIOPIC), PKU, China 0.07
School of Life Sciences, PKU, China 0.07
Translational Cancer Research Center, Peking University First Hospital, China 0.07
Graduate School of Biomedical and Health Sciences (BIMES), HU, Japan 0.06
Duke-NUS Centre for Computational Biology (CCB), Singapore 0.06
Department of Pathology at Tianjin Medical University Cancer Institute and Hospital, TMU, China 0.06
The First Affiliated Hospital of Guangxi Medical University, China 0.06
Department of Cancer Cell Biology at Tianjin Medical University Cancer Institute and Hospital, TMU, China 0.04
MOE Key Laboratory of Carcinogenesis and Cancer Invasion, China 0.03
Department of Anatomical Pathology, SGH, Singapore 0.03
Laboratory of Cancer Epigenome, NCCS, Singapore 0.03
NIH NCI Laboratory of Human Carcinogenesis, United States of America (USA) 0.03
Division of Cellular and Molecular Research (CMR), NCCS, Singapore 0.01
Lymphoma Genomic Translational Laboratory, NCCS, Singapore 0.01
Key Laboratory of Cancer Prevention and Therapy at Tianjin Medical University Cancer Institute and Hospital, TMU, China 0.01
National Clinical Research Center of Cancer at Tianjin Medical University Cancer Institute and Hospital, TMU, China 0.01
Department of Hepatobiliary Tumor at Tianjin Medical University Cancer Institute and Hospital, TMU, China 0.01

Return